Group Telehealth Weight Management Visits for Adolescents With Obesity
2 other identifiers
interventional
66
1 country
1
Brief Summary
Summary Description The goal of this intervention study is to test how well does a weight management curriculum work in virtual group-based medical visits (telehealth) for the treatment of adolescents with obesity. The main questions it aims to answer are:
- How well does providing group-based medical care for obesity using telehealth work?
- How doable is it to provide virtual group-based health education visits with adolescent patients?
- Are the group-based health education visits similar, or better than the traditional in-person clinic visits? Participants will be asked to:
- Complete surveys, do bloodwork, and physical measurements like blood pressure, height and weight before the study activities start and after completing the study activities
- Participate in study activities such as attending 12 virtual sessions lasting 60 minutes each, every other week, over a period of 6 months
- Join group learning and discussions of topics like nutrition, barriers to physical activity, and mental health with various facilitators like a medical doctor, dietitian, psychologist, and physical therapist
- Take part of in brief individual coaching sessions over email or over the phone Researchers will compare the virtual group-based medical visits to the traditional in-person weight management clinic visits (EMPOWER Weight Management Clinic) to see if the study can be another option in the treatment of adolescents with obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 6, 2018
CompletedFirst Posted
Study publicly available on registry
April 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedResults Posted
Study results publicly available
September 9, 2025
CompletedSeptember 9, 2025
September 1, 2025
3.3 years
January 6, 2018
April 24, 2025
September 4, 2025
Conditions
Outcome Measures
Primary Outcomes (7)
Mean Change From Baseline to 6 Months in Body Mass Index
A measure for body adiposity calculated by dividing a participant's weight in kilograms by the square of their height in meters (kg/m\^2)
Baseline to 6 Months
Mean Change From Baseline to 6 Months in Percentage of 95th Percentile Body Mass Index
A measure of body adiposity for severe obesity calculated by dividing a participant's weight in kilograms by the square of their height in meters (kg/m\^2) and categorized as per the American Academy of Pediatrics
Baseline to 6 Months
Mean Change From Baseline to 6 Months in Glycosylated Hemoglobin
a blood test that measures the average blood glucose over three months
Baseline to 6 Months
Mean Change From Baseline to 6 Months in Alanine Aminotransferase
Alanine Aminotransferase (ALT) will be assessed via blood test measured in units/liter. The range from 7 to 56 units per liter (U/L) of blood indicates normal levels and, 57 and greater indicate elevated levels.
Baseline to 6 Months
Mean Change in Triglycerides From Baseline to 6 Months
Triglycerides will be assessed via blood tests and measured in milligrams per deciliter (mg/dL).
Baseline to 6 Months
Mean Change in Diastolic Blood Pressure From Baseline to 6 Months
Blood pressure will be assessed via a blood pressure monitor (a device used to measure blood pressure) measured in millimeters of mercury (mmHg). Systolic mmHg less than 70 indicates normal level, above 70 indicates elevated level, and Diastolic mmHg less than 120 indicates normal level, and above 120 indicates elevated level.
Baseline to 6 Months
Mean Change in Systolic Blood Pressure From Baseline to 6 Months
Blood pressure will be assessed via a blood pressure monitor (a device used to measure blood pressure) measured in millimeters of mercury (mmHg). Systolic mmHg less than 70 indicates normal level, above 70 indicates elevated level, and Diastolic mmHg less than 120 indicates normal level, and above 120 indicates elevated level.
Baseline to 6 Months
Secondary Outcomes (4)
Change in Quality of Life From Baseline to 6 Months Using Quality of Life Questionnaire #1
Baseline to 6 Months
Change in Quality of Life From Baseline to 6 Months Using the Quality of Life 2 (KINDL) Questionnaire.
Baseline to 6 Months
Satisfaction With Care at 6 Months Using Satisfaction Telehealth Questionnaire
6 Months
Attendance/Retention From Baseline to 6 Months
Baseline to 6 Months
Study Arms (2)
Telehealth
EXPERIMENTALThis group will receive weight management treatment via 12 online group sessions, over 6 months. They will have Bluetooth-enabled scales that will allow them to transmit their weight data to the PI in between research visits. They will answer questionnaires and have research visits at baseline, 3 months, and 6 months.
Empower
OTHERThis retrospective control group received standard in-clinic individualized weight management with a multi-disciplinary group of providers, via 6 monthly clinic visits, over 6 months.
Interventions
Telehealth sessions will utilize an online meeting platform and will be conducted by RDs, PTs, psychologists, and MDs, to deliver weight management information/counseling, to group of 5-6 14-18 yos with obesity.
Empower visits for the retrospective control group were multi-disciplinary in nature, occurred at CHLA outpatient clinic, and were intended to be monthly (though actual adherence to recommended attendance was variable). Teen and minimum of one family member were asked to attend monthly visits, as per our standard clinical care.
Eligibility Criteria
You may qualify if:
- Class 2 or 3 obesity OR
- Class 1 obesity plus a significant comorbidity, such as impaired glucose tolerance or type 2 diabetes mellitus, hypertension, hyperlipidemia, non-alcoholic fatty liver disease (NAFLD), polycystic ovarian syndrome (PCOS), or obstructive sleep apnea.
You may not qualify if:
- Significant intellectual or neurodevelopmental disability
- Inability to stand on a scale independently without assistance or use of an assistive device
- Non-English speaking
- Given the shared nature of group appointments, participants should be at approximately the same developmental stage as their peers. Discussion topics may include stigma, body image, family dynamics, and school issues, and therefore a wide variance in age range or cognitive status could potentially diminish the effectiveness of the group sessions. Non-English speaking youth will be excluded due to limitations in translation services for such a small pilot project. English speaking adolescents with non-English speaking parents will be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Related Publications (7)
Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120 Suppl 4:S164-92. doi: 10.1542/peds.2007-2329C.
PMID: 18055651BACKGROUNDBashshur RL, Shannon GW, Smith BR, Alverson DC, Antoniotti N, Barsan WG, Bashshur N, Brown EM, Coye MJ, Doarn CR, Ferguson S, Grigsby J, Krupinski EA, Kvedar JC, Linkous J, Merrell RC, Nesbitt T, Poropatich R, Rheuban KS, Sanders JH, Watson AR, Weinstein RS, Yellowlees P. The empirical foundations of telemedicine interventions for chronic disease management. Telemed J E Health. 2014 Sep;20(9):769-800. doi: 10.1089/tmj.2014.9981. Epub 2014 Jun 26.
PMID: 24968105BACKGROUNDPolisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Scott RE. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare. 2010;16(3):120-7. doi: 10.1258/jtt.2009.090812. Epub 2010 Mar 2.
PMID: 20197355BACKGROUNDHarris MA, Freeman KA, Duke DC. Seeing Is Believing: Using Skype to Improve Diabetes Outcomes in Youth. Diabetes Care. 2015 Aug;38(8):1427-34. doi: 10.2337/dc14-2469. Epub 2015 Jun 1.
PMID: 26033508BACKGROUNDMarkowitz JT, Laffel LM. Transitions in care: support group for young adults with Type 1 diabetes. Diabet Med. 2012 Apr;29(4):522-5. doi: 10.1111/j.1464-5491.2011.03537.x.
PMID: 22150392BACKGROUNDKulik N, Ennett ST, Ward DS, Bowling JM, Fisher EB, Tate DF. Brief report: A randomized controlled trial examining peer support and behavioral weight loss treatment. J Adolesc. 2015 Oct;44:117-23. doi: 10.1016/j.adolescence.2015.07.010. Epub 2015 Aug 7.
PMID: 26265590BACKGROUNDTanofsky-Kraff M, Shomaker LB, Young JF, Wilfley DE. Interpersonal psychotherapy for the prevention of excess weight gain and eating disorders: A brief case study. Psychotherapy (Chic). 2016 Jun;53(2):188-94. doi: 10.1037/pst0000051.
PMID: 27267503BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This study is limited by a relatively small sample size (intervention n = 31, control n=33) and short duration of follow-up (6 months). Study did not reach target number to achieve target power and statistical reliability. Therefore, results should be interpreted with caution until a larger scale and more rigorous study is replicated.
Results Point of Contact
- Title
- Brenda Manzanarez
- Organization
- Children's Hospital Los Angeles
Study Officials
- PRINCIPAL INVESTIGATOR
Brenda Manzanarez
Children's Hospital Los Angeles
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Dietitian II
Study Record Dates
First Submitted
January 6, 2018
First Posted
April 26, 2018
Study Start
January 1, 2018
Primary Completion
April 9, 2021
Study Completion
May 1, 2021
Last Updated
September 9, 2025
Results First Posted
September 9, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share